About
Liquid biopsy is an emerging technique revolutionizing cancer diagnostics by providing a non-invasive method for detecting and analyzing circulating biomarkers such as circulating tumor cells (CTCs) and circulating nucleic acids (cfDNA, ctDNA). This program offers an in-depth exploration of the principles behind liquid biopsy, including the various technologies used for biomarker isolation, quantification, and analysis. Participants will also explore the clinical relevance of liquid biopsy in cancer detection, treatment monitoring, and personalized medicine.
The program combines theoretical knowledge with practical skills, providing participants with hands-on experience in liquid biopsy technologies, from sample collection and processing to data analysis. The course also covers the regulatory and ethical considerations necessary for implementing liquid biopsy in clinical practice, offering a comprehensive view of how circulating biomarker analysis can significantly impact cancer treatment and patient outcomes.
Aim
The program aims to equip participants with advanced knowledge in liquid biopsy techniques and circulating biomarker analysis for non-invasive cancer detection and monitoring. The course focuses on the identification, isolation, and characterization of circulating tumor cells (CTCs) and circulating nucleic acids (cfDNA, ctDNA) for early diagnosis, prognosis, and therapeutic monitoring.
Program Objectives
- Understand the fundamentals of liquid biopsy and circulating biomarker analysis.
- Gain proficiency in the techniques for isolating and characterizing circulating biomarkers.
- Explore the clinical applications of liquid biopsy in cancer detection and monitoring.
- Evaluate the current technologies used for circulating tumor cell and nucleic acid detection.
- Analyze case studies and clinical trial data related to liquid biopsy and its impact on personalized medicine.
Program Structure
Week 1: Introduction to Liquid Biopsy and Circulating Biomarkers
Overview of non-invasive diagnostic techniques
Clinical relevance of circulating biomarkers
Benefits and limitations of liquid biopsy in modern medicine
Week 2: Technologies for Circulating Tumor Cell (CTC) and cfDNA Analysis
Techniques for isolating and characterizing circulating tumor cells (CTCs) and cell-free DNA (cfDNA)
Advances in biomarker detection technologies
Practical demonstrations on sample processing
Week 3: Applications in Cancer Detection and Monitoring
Case studies on liquid biopsy in early cancer detection and prognosis
Monitoring therapy effectiveness through liquid biopsy
Comparative analysis of traditional vs. liquid biopsy approaches
Week 4: Clinical Trial Data, Ethical Considerations, and Practical Workshop
Review of clinical trial data on liquid biopsy applications
Discussion on regulatory guidelines and patient privacy in diagnostics
Hands-on training in liquid biopsy techniques and data analysis
Participant’s Eligibility
- Undergraduate degree in Life Sciences, Biotechnology, or Biomedical Engineering.
- Professionals in clinical diagnostics, cancer research, or molecular biology.
- Researchers and technologists in oncology and biomarker discovery.
Program Outcomes
- Mastery of liquid biopsy techniques and circulating biomarker analysis.
- Ability to perform non-invasive cancer detection using advanced molecular technologies.
- Understanding of clinical and regulatory aspects of liquid biopsy in oncology.
- Practical experience with liquid biopsy technologies such as cfDNA and CTC analysis.
- Knowledge of how circulating biomarkers contribute to personalized cancer therapies.
Program Deliverables
- Access to e-LMS
- Real-Time Project for Dissertation
- Project Guidance
- Paper Publication Opportunity
- Self Assessment
- Final Examination
- e-Certification
- e-Marksheet